This research determines the ground for a Christian theological anthropology that makes provision for a doctrine that supports human self-realization. It is evident from the study that anthropological self-realization is an involved process of becoming truly human, not an isolated course founded solely on the biblical knowledge of being created in the image and likeness of God. All sciences, and in particular anthropological sciences, enjoy the prerogative of unraveling and analyzing the human person. Whether these sciences are neuro-biological, psychological, theological, philosophical, biblical, spiritual or mystical in character, each with its specific method legitimately attempts to explain the complexities of the human person. In the light of this neither philosophy nor theology possess the exclusive claim to authentic human wisdom. In truth most scientific insights have a combined impact on the self-realizing growth and development of humanity. The process of self-realization links theology to real life questions such as evil, suffering, hope, love, justice and freedom, as well as with the immanent, the transcendent, the human and the divine. This thesis holds to the opinion that a theology of self-realization would contribute to the 'humanization' of theology since it brings praxis and theory into close alignment. This study equally expresses the conviction that the doctrine of consecrated vowed life, an ecclesiastical structure in the Roman Catholic Church, is particularly in need of humanization, as the notion of 'self' as a strength has been notably absent from traditional treatises on the practices of religious life. Conventional forms of consecrated vowed life called the woman to suppress and spiritualize at least some of her femininity. This was due to the distorted theological anthropology that sustained consecrated life in which God was presented as an idea to be grasped intellectually, and not an experience to be lived. / Philosophy, Practical & Systematic Theology / Th. D. (Systematic Theology)

The intention of this study was theory creation in the field of organisational change, directed towards the creation of a conceptual change framework. A qualitative research approach was followed and a grounded theory methodology adopted. This study involved a theoretical investigation of organisational change and leadership within South African organisations, although insights gained could be transferred across contexts or settings. The primary aim was to create a practical change framework to ensure sustainable organisational change. Secondly, to determine the impact of leadership on successful organisational change. Thirdly, to establish whether any fundamental elements can be identified as essential for inclusion in such a change framework. Fourthly, to identify non-negotiable success factors that can ensure successful change. Fifthly, to determine the human elements that should be included in order to minimise negative outcomes such as resistance and noncompliance. The final aim was to ascertain what meta-insights can be gained from organisational change and leadership. The research findings concluded that the first perception when speaking about change is fear, anxiety and increased stress, resulting in impaired functioning. Organisations struggle to handle increased stress levels during periods of change and require improved methods of dealing with stress to ensure optimal individual functioning. Only through reduced stress levels will individuals be able to engage with organisational change initiatives. Alternative intervention technologies were suggested which could assist the individual change journey through reduced stress and/or increased consciousness. These alternative intervention technologies were suggested because of the paucity of current literature. It practically aids organisations on how to deal with the stress dilemma. This research introduced the concepts of anti-leader and anti-manager. These concepts depict the negative characteristics of leadership and management which invariably increases individual stress levels. Emotions elicited by the anti-leader and/or anti-manager could potentially split, divide and fragment a workforce. The ideal organisational approach should be designed by the people, be inclusive of all, involve, empower and allow individuals to make the required decisions. As organisational change can only be effected through individual change, this thesis places the individual in the centre. Without individual change, vicissitude and sustainable organisational change become highly unlikely. / Business Management / DBL

Submitted in complete fulfillment for the degree of Doctor of Philosophy (Biotechnology), Durban University of Technology, Durban, South Africa, 2016. / Seasonal nitrification breakdown is a major problem in wastewater treatment plants which makes it difficult for the plant operators to meet discharge limits. The present study focused on understanding the seasonal impact of environmental and operational parameters on nitrifiers and nitrification, in a biological nutrient removal wastewater treatment works situated in the midlands of KwaZulu Natal. Composite sludge samples (from the aeration tank), influent and effluent water samples were collected twice a month for 237 days. A combination of fluorescent in-situ hybridization, polymerase chain reaction (PCR)-clone library, quantitative polymerase chain reaction (qPCR) were employed for characterizing and quantifying the dominant nitrifiers in the plant. In order to have more insight into the activated sludge community structure, pyrosequencing was used in profiling the amoA locus of ammonia oxidizing bacteria (AOB) community whilst Illumina sequencing was used in characterising the plant’s total bacterial community. The nonlinear effect of operating parameters and environmental conditions on nitrification was also investigated using an adaptive neuro-fuzzy inference system (ANFIS), Pearson’s correlation coefficient and quadratic models. The plant operated with higher MLSS of 6157±783 mg/L during the first phase (winter) whilst it was 4728±1282 mg/L in summer. The temperature recorded in the aeration tanks ranged from 14.2oC to 25.1oC during the period. The average ammonia removal during winter was 60.0±18% whereas it was 83±13% during summer and this was found to correlate with temperature (r = 0.7671; P = 0.0008). A significant correlation was also found between the AOB (amoA gene) copy numbers and temperature in the reactors (α= 0.05; P=0.05), with the lowest AOB abundance recorded during winter. Sanger sequencing analysis indicated that the dominant nitrifiers were Nitrosomonas spp. Nitrobacter spp. and Nitrospira spp. Pyrosequencing revealed significant differences in the AOB population which was 6 times higher during summer compared to winter. The AOB sequences related to uncultured bacterium and uncultured AOB also showed an increase of 133% and 360% respectively when the season changed from winter to summer. This study suggests that vast population of novel, ecologically significant AOB species, which remain unexploited, still inhabit the complex activated sludge communities. Based on ANFIS model, AOB increased during summer season, when temperature was 1.4-fold higher than winter (r 0.517, p 0.048), and HRT decreased by 31% as a result of rainfall (r - 0.741, p 0.002). Food: microorganism ratio (F/M) and HRT formed the optimal combination of two inputs affecting the plant’s specific nitrification (qN), and their quadratic equation showed r2-value of 0.50. This study has significantly contributed towards understanding the complex relationship between the microbial population dynamics, wastewater composition and nitrification performance in a full-scale treatment plant situated in the subtropical region. This is the first study applying ANFIS technique to describe the nitrification performance at a full-scale WWTP, subjected to dynamic operational parameters. The study also demonstrated the successful application of ANFIS for determining and ranking the impact of various operating parameters on plant’s nitrification performance, which could not be achieved by the conventional spearman correlation due to the non-linearity of the interactions during wastewater treatment. Moreover, this study also represents the first-time amoA gene targeted pyrosequencing of AOB in a full-scale activated sludge is being done. / D

Les micelles polyioniques ont émergé comme des systèmes prometteurs de relargage de médicaments hydrophiles ioniques. Le but de cette étude était le développement des micelles polyioniques à base de dextrane pour la relargage de médicaments hydrophiles cationiques utilisant une nouvelle famille de copolymères bloc carboxymethyldextran-poly(éthylène glycol) (CMD-PEG). Quatre copolymères CMD-PEG ont été préparés dont deux copolymères identiques en termes de longueurs des blocs de CMD et de PEG mais différent en termes de densité de charges du bloc CMD; et deux autres copolymères dans lesquels les blocs chargés sont les mêmes mais dont les blocs de PEG sont différents. Les propriétés d’encapsulation des micelles CMD-PEG ont été évaluées avec différentes molécules cationiques: le diminazène (DIM), un médicament cationique modèle, le chlorhydrate de minocycline (MH), un analogue semi-synthétique de la tétracycline avec des propriétés neuro-protectives prometteuses et différents antibiotiques aminoglycosidiques. La cytotoxicité des copolymères CMD-PEG a été évaluée sur différentes lignées cellulaires en utilisant le test MTT et le test du Bleu Alamar. La formation de micelles des copolymères de CMD-PEG a été caractérisée par différentes techniques telles que la spectroscopie RMN 1H, la diffusion de la lumière dynamique (DLS) et la titration calorimétrique isotherme (ITC). Le taux de relargage des médicaments et l’activité pharmacologique des micelles contenant des médicaments ont aussi été évalués. Les copolymères CMD-PEG n'ont induit aucune cytotoxicité dans les hépatocytes humains et dans les cellules microgliales murines (N9) après 24 h incubation pour des concentrations allant jusqu’à 15 mg/mL. Les interactions électrostatiques entre les copolymères de CMD-PEG et les différentes drogues cationiques ont amorcé la formation de micelles polyioniques avec un coeur composé du complexe CMD-médicaments cationiques et une couronne composée de PEG. Les propriétés des micelles DIM/CMDPEG ont été fortement dépendantes du degré de carboxyméthylation du bloc CMD. Les micelles de CMD-PEG de degré de carboxyméthylation du bloc CMD ≥ 60 %, ont incorporé jusqu'à 64 % en poids de DIM et ont résisté à la désintégration induite par les sels et ceci jusqu'à 400 mM NaCl. Par contre, les micelles de CMD-PEG de degré de carboxyméthylation ~ 30% avaient une plus faible teneur en médicament (~ 40 % en poids de DIM) et se désagrégeaient à des concentrations en sel inférieures (∼ 100 mM NaCl). Le copolymère de CMD-PEG qui a montré les propriétés micellaires les plus satisfaisantes a été sélectionné comme système de livraison potentiel de chlorhydrate de minocycline (MH) et d’antibiotiques aminoglycosidiques. Les micelles CMD-PEG encapsulantes de MH ou d’aminoglycosides ont une petite taille (< 200 nm de diamètre), une forte capacité de chargement (≥ 50% en poids de médicaments) et une plus longue période de relargage de médicament. Ces micelles furent stables en solution aqueuse pendant un mois; après lyophilisation et en présence d'albumine sérique bovine. De plus, les micelles ont protégé MH contre sa dégradation en solutions aqueuses. Les micelles encapsulant les drogues ont maintenu les activités pharmacologiques de ces dernières. En outre, les micelles MH réduisent l’inflammation induite par les lipopolysaccharides dans les cellules microgliales murines (N9). Les micelles aminoglycosides ont été quant à elles capable de tuer une culture bactérienne test. Toutefois les micelles aminoglycosides/CMDPEG furent instables dans les conditions physiologiques. Les propriétés des micelles ont été considérablement améliorées par des modifications hydrophobiques de CMD-PEG. Ainsi, les micelles aminoglycosides/dodecyl-CMD-PEG ont montré une taille plus petite et une meilleure stabilité aux conditions physiologiques. Les résultats obtenus dans le cadre de cette étude montrent que CMD-PEG copolymères sont des systèmes prometteurs de relargage de médicaments cationiques. / Polyion complex (PIC) micelles have emerged as promising delivery systems of ionic hydrophilic drugs. It was the aim of this study to develop dextran-based PIC micelles for the delivery of hydrophilic cationic drugs using a new family of carboxymethyldextranblock- poly(ethylene glycol) (CMD-PEG) copolymers. Four CMD-PEG copolymers were prepared: (i) two copolymers identical in terms of the length of CMD and PEG blocks, but different in terms of the charge density of the CMD block; and (ii) two copolymers in which the charged block is the same, but the PEG block is of different molecular weight. The micellization of CMD-PEG copolymers and drug delivery aspects of the resulting micelles were evaluated using different cationic drugs: diminazene (DIM), a model cationic drug, minocycline hydrochloride (MH), a semisynthetic tetracycline antibiotic with promising neuroprotective properties and different aminoglycoside antibiotics. The cytotoxicity of CMD-PEG copolymers was evaluated in different cell lines using MTT and Alamar blue assays. CMD-PEG micelles encapsulating different drugs were characterized using different techniques, such as 1H NMR spectroscopy, dynamic light scattering (DLS), and isothermal titration calorimetry (ITC). The pattern of drug release and pharmacological activity of micelles-encapsulated drugs were also evaluated. The CMD-PEG copolymers did not induce cytotoxicity in human hepatocytes and murine microglia (N9) in concentrations as high as 15 mg/mL after incubation for 24 h. Electrostatic interactions between CMD-PEG copolymers and different cationic drugs triggered the formation of PIC micelles with a CMD/drug core and a PEG corona. The properties of DIM/CMD-PEG micelles were strongly dependent on the degree of carboxymethylation of the CMD block. Micelles of CMD-PEG copolymers having degree of carboxymethylation ≥ 60%, incorporated up to 64 wt% DIM, resisted salt-induced disintegration in solutions up to 400 mM NaCl and sustained DIM release under physiological conditions (pH 7.4, 150 mM NaCl). In contrast, micelles of CMD-PEG of degree of carboxymethylation ~ 30% had lower drug content (~ 40 wt% DIM) and disintegrated at lower salt concentration (∼ 100 mM NaCl). The CMD-PEG copolymer that showed the most satisfactory micellar properties, in terms of high drug loading capacity, sustained drug release and micelles stability was selected as a potential delivery system of minocycline hydrochloride (MH) and different aminoglycosides. CMD-PEG micelles encapsulating either MH or aminoglycosides had small size (< 200 nm in diameter), high drug loading capacity (≥ 50 wt% drug) and sustained drug release. These micelles were stable in aqueous solution for up to one month, after freeze drying and in the presence of bovine serum albumin. Furthermore, the micelles protected MH against degradation in aqueous solutions. Micelles-encapsulated drugs maintained their pharmacological activity where MH micelles reduced lipopolysaccharides-induced inflammation in murine microglia (N9) cells. And aminoglycosides micelles were able to kill a test micro-organism (E. coli X-1 blue strain) in culture. Aminoglycosides/CMD-PEG micelles were unstable under physiological conditions. Micelle properties were greatly enhanced by hydrophobic modification of CMD-PEG. Thus, aminoglycosides/dodecyl-CMD-PEG micelles showed smaller size and better stability under physiological conditions. The results obtained in this study show that CMD-PEG copolymers are promising delivery systems for cationic hydrophilic drugs.

Dans les maladies neurodégénératives comme la sclérose en plaques, la neuro-inflammation modifie l'activité de la barrière hémato-encéphalique (BHE) par des altérations cellulaires et moléculaires complexes. La caractérisation de tels changements moléculaires par une approche d'étiquetage in vivo justifie la recherche d’outils de ciblage fiables et de biomarqueurs. Les stratégies pour définir in vivo ces marqueurs sont cependant compliquées par la pléthore de molécules cibles accessibles, par l’intrication des régions atteintes au sein du tissu sain et par les altérations structurales potentielles des molécules cibles étudiées par histopathologie. Le but de ce travail est de rationaliser la découverte de biomarqueurs des altérations moléculaires dans les tissus par une stratégie de sélection in vivo de répertoires de phages présentant des peptides à leur surface (phage display), les ligands présents dans les deux répertoires (sain et pathologique) étant ensuite soustraits physiquement. Cette stratégie de soustraction (« PhiSSH ») permettant d’enrichir un répertoire en ligands spécifiques est d’un intérêt majeur dans le cas de répertoires complexes tels ceux obtenus dans des sélections in vivo.Nous présentons l'application de cette stratégie dans le modèle de rat de la sclérose en plaques, l’Encéphalomyélite Autoimmune Expérimentale (EAE), où les lésions disséminées dans le système nerveux central engendrent la sélection d’une grande quantité de clones s’associant au tissu sain, par comparaison avec les rats témoins en bonne santé. L'efficacité de la technique de soustraction a été contrôlée par séquençage massif des trois repertoires, «EAE», «SAIN», et «SOUSTRACTION». Plus de 95 % des clones communs aux répertoires EAE et contrôle sont absents du répertoire de la soustraction. Un ensemble de clones de phages et des peptides synthétisés chimiquement dessinés après l’analyse bioinformatique du répertoire de soustraction a été testé a) sur des tissus de rats EAE et sains et b) sur des cellules humaines en culture (HCMEC/D3) constituant un modèle de BHE, dans des conditions inflammatoires, (activation IL- 1ß) ou non activées. Un des clones et quatre peptide testés ont montré une association spécifique sur les cellules endothéliales de BHE dans des conditions inflammatoires. Pour identifier la cible d’un phage spécifique des lésions neuro-inflammatoires, nous avons mis en œuvre un procédé de création de liaison covalente entre ce phage et les protéines exprimées par des cellules de BHE cultivées en présence d’IL-1ß, puis effectué une analyse par spectométrie de masse. La galectine-1 est apparue comme une cible potential de ce phage. La découverte de biomarqueurs spécifiques de modifications moléculaires et cellulaires de régions inflammatoires disséminées dans les tissus sains, comme c’est le cas dans la plupart des pathologies présentant une activité neuro–inflammatoire, sera facilitée par l’utilisation de la stratégie de soustraction PhiSSH décrite dans ce document. / In neurodegenerative disorders like multiple sclerosis, neuroinflammation modifies the blood brain barrier (BBB) status by causing complex cellular and molecular alterations. Characterization of such molecular changes by an in vivo labeling approach is most challenging to generate reliable in vivo targeting tools and biomarkers. In vivo strategies to define such markers are, however, hampered by the plethora of the accessible target molecules, the vicinity of diseased target expression among healthy tissue and the potentially structural alterations of target molecules when studied by histopathology. The aim of this work is to streamline the biomarker discovery of pathological molecular tissue alterations by in vivo selection of phage displayed peptide repertoires that are further submitted to physical DNA subtraction (“PhiSSH”) of sequences encoding common peptides in both repertoires (HEALTHY and PATHOLOGY). The strategy of Subtraction allows thus the enrichment of clones specific for one repertoire and is of particular interest for complex repertoires produced by in vivo selection. We present the application of this strategy in the multiple sclerosis rat model, Experimental Autoimmune Encephalomyelitis (EAE) pathology, where target lesions are disseminated in the central nervous system (CNS) generating a large amount of clones binding to healthy tissue among the recovered repertoire clones binding to the lesions by comparison with healthy control rats. The efficiency of the subtraction was monitored by massive sequencing of the three repertoires, «EAE», «HEALTHY», and «SUBTRACTION». More than 95% of the clones common to EAE and Healthy repertoires were shown to be absent from the Subtraction repertoire. A set of randomly chosen clones and synthesized peptides from the EAE and subtraction repertoires were tested for differential labeling of a) diseased and healthy animal tissues and b) an in vitro BBB model, in IL-1ß challenged and resting control state culture human cells (hCMEC/D3). One of the phage clones and 4 chemically synthesized peptides showed specific binding to brain ECs in neuro-inflammatory conditions. Using a strategy of crosslinking of an EAE specific phage clone on protein targets expressed by IL-1ß activated ECs followed by mass spectrometry, we propose hypothetically Galectin-1 as a possible target of this phage. PhiSSH will be useful for in vivo screening of small peptide combinatorial libraries for the discovery of biomarkers specific of molecular and cellular alterations untangled with healthy tissues, as in most pathologies presenting neuroinflammatory activity.

Student Number : 8315331 - MSc dissertation - School of Electrical and Information Engineering - Faculty of Engineering and the Built Environment / In this dissertation an efficient algorithm to calculate the differential of the network output with respect to its inputs is derived for axis orthogonal Local Model (LMN) and Radial Basis Function (RBF) Networks. A new recursive Singular Value Decomposition (SVD) adaptation algorithm, which attempts to circumvent many of the problems found in existing recursive adaptation algorithms, is also derived. Code listings and simulations are presented to demonstrate how the algorithms may be used in on-line adaptive neurocontrol systems. Specifically, the control techniques known as series inverse neural control and instantaneous linearization are highlighted. The presented material illustrates how the approach enhances the flexibility of LMN networks making them suitable for use in both direct and indirect adaptive control methods. By incorporating this ability into LMN networks an important characteristic of Multi Layer Perceptron (MLP) networks is obtained whilst retaining the desirable properties of the RBF and LMN approach.

A lesão medular pode prejudicar a marcha de um indivíduo. Para estes casos, uma técnica de reabilitação que tem se tornado mais popular é a Estimulação Elétrica Neuro Muscular (EENM). Na marcha assistida por EENM tradicional, o controle da estimulação é realizado utilizando-se acionamento manual, um fato que ajuda a torná-la distante da marcha saudável. Este trabalho propõe um sistema que monitora variáveis da marcha - ângulos da articulação do joelho, e forças de reação do solo (retropé e antepé) - e as utiliza como entradas para uma rede neural artificial (RNA), a fim de poder controlar automaticamente a EENM na marcha. Os transdutores utilizados para medir ângulos foram eletrogoniômetros, montados nos membros inferiores do indivíduo utilizando tiras de velcro. Para medição das forças, os transdutores utilizados foram células de carga construídas com strain gages, montadas em sandálias instrumentadas. Os métodos para construção do hardware de aquisição de dados (transdutores e interface) e do software estão descritos, bem como os métodos de calibração dos transdutores. Todos os transdutores apresentaram comportamento linear. Testes iniciais foram realizados, utilizando primeiramente um indivíduo saudável, e depois dois pacientes que normalmente realizam treinamento de marcha com suspensão de peso (assistida por EENM ou não). Os resultados mostraram que o módulo de monitoramento permite gravar os dados coletados, e realizar comparações entre padrões de marcha de diferentes indivíduos, bem como diferentes estágios de reabilitação para um mesmo indivíduo. O treinamento da RNA para o indivíduo saudável apresentou uma taxa de acerto próxima de 90%, e para os pacientes lesados medulares a taxa foi de cerca de 80%. O módulo de controle apresentou resultados promissores nos testes práticos realizados, com respostas rápidas e corretas para o indivíduo saudável. Sugestões para trabalhos futuros foram dadas, para que testes práticos de controle possam ser realizados utilizando pacientes lesados medulares. / Spinal cord injury (SCI) may impair an individual\'s gait. For these cases, a rehabilitation technique that has become more popular is functional electrical stimulation (FES). On traditional FES-assisted gait, the stimulation control is performed with manual triggering, a fact that helps make it distant from healthy gait. This work proposes a system that monitors gait variables - knee joint angles, and ground reaction forces (rearfoot and forefoot) - and uses them as inputs for an Artificial Neural Network (ANN), in order to be able to automatically control gait FES. The transducers used for angle measurement were electrogoniometers, mounted on the individuals lower limbs using Velcro straps. For force measurement, the transducers used were load cells built with strain gages, mounted on instrumented sandals. The methods for building the data acquisition hardware (transducers and interface) and software are described, along with the transducer calibration methods. All transducers presented linear behavior. Initial tests were performed, using first a healthy individual, and then a couple of patients that normally undergo suspended gait raining (FES-assisted or not). The results showed that the monitoring module allows recording the data collected, and making comparison between different individuals\' gait patterns, as well as different rehabilitation stages for the same individual. The ANN training for the healthy individual presented an accuracy rate close to 90%, and for the SCI patients the rate was about 80%. The control module showed promising results on practical tests performed, with quick and accurate responses for the healthy individual. Suggestions for future works were given, so that practical control tests can be performed using SCI patients.

Les synucléionopathies représentent un groupe de maladies neuro-dégénératives incurables du système nerveux central. Elles regroupent entre autres la maladie de Parkinson, l’atrophie multi-systématisée et la maladie à corps de Lewy. Toutes ces maladies se caractérisent par un déclin progressif des fonctions motrices, cognitives, comportementales et autonomiques. La mal-conformation et l’agrégation de la protéine α-synuclein qui forme des inclusions intraneuronales sont des éléments communs à toutes les synucleinopathies. Ces inclusions portent le nom de corps de Lewy et se forment dans des neurones ou cellules gliales appartenant à des régions cérébrales spécifiques. Elles sont vraisemblablement à l’origine de la perte progressive de neurones dans certaines parties du cerveau. Dans le cas de la maladie de Parkinson et dans d’autres maladies neuro-dégénératives, il a été démontré que la pathologie se propage anatomiquement d’une manière spécifique et prévisible au niveau cérébrale. Ceci suggère donc que la progression de la maladie est étroitement liée au transfert des agrégats d’α-synucléine. Ce procédé est très similaire à celui impliqué dans la maladie du prion qui elle en revanche est infectieuse. Par ailleurs, des inclusions neuronales d’α-synucléine ont été identifiées dans des neurones dopaminergiques d’origine fœtaux qui avaient été transplanté dans des cerveaux de patients parkinsoniens. Cette étude a permis d’envisager pour la première fois la possibilité de la transmission d’inclusions d’α-synucléine entre les neurones. Bien que de nombreuses études aient démontré la propagation d’α-synucléine in vitro et in vivo, le mécanisme permettant ce transfert n’est pas clairement établi. Par conséquent, ma thèse s’attache à étudier le mécanisme de transfert d’assemblages d’α-synucléine (i.e., oligomères et fibrilles). Dans un premier temps, j’ai apporté la preuve que les assemblages d’α-synucléine transfèrent de manière efficace entre les cellules neuronales via les Tunneling nanotubes (TNT). Les TNT sont définis comme étant des ponts membranaires riches en F-actine et permettant de connecter physiquement le cytoplasme de cellules éloignées. Au niveau subcellulaire, j’ai démontré que les assemblages d’α-synucléine qui transfèrent se trouvent dans des lysosomes. En revanche, après le transfert, ces assemblages se retrouvent libres dans le cytoplasme. J’ai également mis en évidence qu’à la suite du transfert, permis par les TNT, les fibrilles d’α-synucléine sont capables de recruter et d’induire l’agrégation de l’α-synucléine soluble afin de perpétuer le processus d’agrégation à l’infinie. Ces résultats indiquent que les TNT peuvent représenter un moyen efficace permettant le transfert d’assemblages d’α-synucléine. Cette découverte offre de nouvelles opportunités pour le développement de nouveaux agents neuro-protectifs contre la propagation des synucléinopathies. / Synucleinopathies are a group of fatal neurodegenerative diseases including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, characterized by a chronic and progressive decline in motor, cognitive, behavioral, and autonomic functions. The hallmark of these diseases is the misfolding and aggregation of α-synuclein protein accumulating into intracellular inclusions Lewy bodies in neurons and glial cells which leads to the loss of neurons in specific brain regions. In the case of Parkinson’s disease and other neurodegenerative diseases, the pathology was shown to progress throughout the brain in a specific and predictable manner suggesting that the progression of the diseases is linked to the transfer of aggregated α-synuclein that is reminiscent of prion diseases that are infectious. Importantly, upon transplantation of fetal dopaminergic neurons in the brain of Parkinson’s patients, neuronal inclusions were found in the grafted neurons strongly suggesting that α-synuclein inclusions could transmit between neurons. While several studies showed α-synuclein propagation in vitro and in vivo the mechanism of intercellular transfer remains elusive. The aim of my thesis was to study the mechanism of transfer of α-synuclein assemblies (i.e., oligomers and fibrils) involved in Parkinson’s pathogenesis. I evidenced that α-synuclein assemblies transferred efficiently via tunneling nanotubes (TNT), F-actin based membranous bridges connecting the cytoplasm of remote cells. I demonstrated that, at the sub-cellular level, the transferred α-synuclein assemblies were specifically confined in lysosomes and that upon transfer a large amount of α-synuclein was found free in the cytosol of acceptor cells. Finally, I showed that after TNT-mediated transfer α-synuclein fibrils recruited and seeded the aggregation of the soluble α-synuclein protein in order to perpetuate aggregation. The identification of TNT as an efficient means of α-synuclein transfer opens new avenues to the development of novel therapies targeting the spreading into the brain of amyloidogenic proteins involved in neurodegenerative diseases.

In recent years, numerous high tech companies have developed and used technology roadmaps when making their investment decisions. Jay Paap has proposed the Customer Focused Technology Planning (CFTP) framework to draw future technology roadmaps. However, the CFTP framework does not include risk assessment as a critical factor in decision making. The problem addressed in this quantitative study was that high tech companies are either losing money or getting a much smaller than expected return on investment when making technology investment decisions. The purpose of this research was to determine the relationship between returns on investment before and after adding risk assessment to the CFTP framework. Paap's CFTP framework and process to improve technology investments thus served as the theoretical framework for this study. Data were obtained from cloud computing companies using the companies' market risk data and actual returns on investment data. The results and findings of paired sample two-tailed t tests for means and equal variances showed that return on investment was positively related to adding a traditional risk assessment model to Paap's CFTP framework. These findings regarding the addition of risk assessment to the technology investment framework may be used by investors to (a) make better and more expeditious decisions, and (b) obtain a high return on technology investment by selecting the highest return value and lowest risk value.

Dans le cadre du programme commun d’études pharmaco-épidémiologiques de la caisse nationale de l'assurance maladie et de l’agence nationale de sécurité du médicament, visant à évaluer l'impact sanitaire en France de l'exposition in utero à l’acide valproïque à partir des bases de données médico-administratives (BDMA) françaises, l’objectif de cette thèse était d’étudier l’utilisation des antiépileptiques pendant la grossesse et les risques de malformations congénitales et de troubles neuro-développementaux associés chez l’enfant. Le premier volet de cette thèse a consisté à formaliser et publier un algorithme d’identification des grossesses spécifiquement adapté aux BDMA françaises. L’application de cet algorithme à la description de l’utilisation des antiépileptiques pendant la grossesse a permis d’estimer à 6,7‰ la prévalence de l’utilisation des antiépileptiques pendant la grossesse et de montrer une baisse de l’utilisation des antiépileptiques de première génération, en particulier de l’acide valproïque, au bénéfice des antiépileptiques de deuxième génération entre 2007 et 2014. Dans le deuxième volet de cette thèse, l’exposition in utero à l’acide valproïque a été retrouvée associée à une augmentation du risque d’un grand nombre des malformations congénitales majeures (MCM) étudiées, avec une relation dose-effet pour les MCM les plus fréquentes, et l’exposition in utero au topiramate à une augmentation du risque de fentes oro-faciales. Des signaux relatifs à la prégabaline, au clonazépam et au phénobarbital ont aussi été identifiés. Dans le troisième volet de cette thèse, l’exposition in utero à l’acide valproïque a été retrouvée associée à une augmentation du risque de chacun des événements neuro-développementaux précoces étudiés versus lamotrigine, avec une relation dose-effet, à l’inverse des autres antiépileptiques. La réalisation d’études pharmaco-épidémiologiques à partir des BDMA françaises a permis aux autorités sanitaires de fournir rapidement des données sur l’utilisation des antiépileptiques pendant la grossesse en France. La réalisation de ces études a aussi permis de participer à l’enrichissement de la littérature observationnelle internationale sur les conséquences de l’exposition in utero aux antiépileptiques pour l’enfant à naitre. / The works of this thesis have been carried out within a programme of pharmacoepidemiological studies initiated by the National Agency of Medicine and Health Product Safety (ANSM) and the National Health Insurance fund (Cnam) in order to evaluate the public health situation in relation to prenatal exposure to valproic acid in France on the basis of the French health care databases. The objective of this thesis was to study antiepileptic drug (AED) use during pregnancy and the risks of congenital malformations and neurodevelopmental disorders associated with prenatal exposure to these drugs. In a first study, we developed an algorithm to identify pregnancy episodes and related outcomes using the French health care claims databases and applied it to study AED use during pregnancy between 2007 and 2014. Over the study period, 6.7 per 1000 pregnancies were exposed to an AED. The use of newer AEDs increased concomitantly with the decreased use of valproic acid and the other older AEDs. In a second study, prenatal exposure to valproic acid was found to be associated with a wide range of malformations among those investigated, with a dose-response relationship for half of them, and prenatal exposure to topiramate with an increased risk of cleft lip with or without cleft palate. Signals concerning pregabalin, clonazepam and phenobarbital have also been identified. In a third study, prenatal exposure to valproic acid was found to be associated with increased risks of all early neurodevelopmental outcomes investigated compared with lamotrigine, with a dose-response relationship. Prenatal exposure to the other AEDs was not associated with an increased risk of any of these neurodevelopmental outcomes versus lamotrigine. Conducting pharmacoepidemiological studies based on the French health care databases enabled the health authorities to rapidly provide data on the use of AED during pregnancy in France. It also brought additional evidence to the international observational literature on the consequences of prenatal exposure to AEDs for the unborn child.